Skip to main content
Year archive

CORESTEMCHEMON Inc. — 2022 filings

All 51 regulatory filings released by CORESTEMCHEMON Inc. (166480) in 2022, sourced directly from the official regulator.

51 Filings
2022 Period
2022 filings (51)
Filing Released Lang
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2022-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-09 Korean
증권발행실적보고서(합병등)
Share Issue/Capital Change
2022-12-02 Korean
대표이사변경
Board/Management Information
2022-12-02 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-11 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-10-11 Korean
상호변경안내
Regulatory Filings
2022-10-11 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-10-11 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2022-09-26 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-09-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-09-19 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-09-19 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2022-09-15 Korean
[기재정정]투자설명서
M&A Activity
2022-09-15 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement
2022-09-15 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2022-09-06 Korean
[기재정정]투자설명서
M&A Activity
2022-09-06 Korean
투자설명서
Share Issue/Capital Change
2022-09-05 Korean
[기재정정]증권신고서(합병)
M&A Activity
2022-08-24 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
주권매매거래정지(합병)
Delisting Announcement
2022-08-16 Korean
주요사항보고서(회사합병결정)
M&A Activity
2022-08-16 Korean
증권신고서(합병)
M&A Activity
2022-08-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-08-16 Korean
[첨부추가]주주총회소집결의
Proxy Solicitation & Information Statement
2022-08-16 Korean
투자판단관련주요경영사항(근위축성측삭경화증(루게릭병) 환자를 대상으로 HypoThermosol® FRS (HTS-FRS)를 현탁화제로 혼합한 뉴로나타-알주(자가골수유래중간엽줄기세포)의 안전성 평가를 위한 제 1상 임상시험 계획(IND) 승인)
Regulatory Filings
2022-08-08 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2022-06-27 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-28 Korean
전환가액의조정
Capital/Financing Update
2022-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-25 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-17 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-14 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회소집공고
AGM Information
2022-03-04 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-24 Korean
주주총회소집결의
AGM Information
2022-02-24 Korean
기타시장안내(연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings
2022-01-04 Korean